The Omnipath Combi SARS-CoV-2 IgG ELISA detects and quantifies antibodies against the coronavirus and increases the University of Oxford’s testing capacity to up to 50,000 tests per day.
Read More
The combined test to detect and differentiate covid-19, influenza, and/or respiratory syncytial virus in individuals with respiratory symptoms consistent with covid-19.
Read More
Using “lab on a chip” technology, Stanford University engineers have created a microlab half the size of a credit card that can detect covid-19 in 30 minutes.
Read More
The companies aim to make CoviSafe an ultrasensitive, rapid, saliva-based, point-of-care lateral flow test for SARS-CoV-2.
Read More
SARS-CoV-2 reactive T cells may be sufficient to give protection from covid-19, and serology alone may underestimate those at lower risk of clinical SARS-CoV-2 infection.
Read More